Targeting TAZ-TEAD pathway in hepatocellular carcinoma with pan-TEAD inhibition

被引：0
|
作者：
Saito, Yoshinobu [1 ]
Hikita, Hayato [1 ]
Kodama, Takahiro [1 ]
Schwabe, Robert [1 ]
Takehara, Tetsuo [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Gastroenterol & Hepatol, Osaka, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-3017
引用
收藏
页码：1362 / 1362
页数：1
相关论文
共 50 条
  • [1] Targeting the YAP/TAZ-TEAD pathway with TEAD inhibitors synergizes with chemotherapy and blocks diffuse gastric cancer progression
    Bulakhova, Anastasiia
    Cho, Jin Sun
    Rifkin, Jack T.
    Kim, Jaewon
    Ryan, Thomas J.
    Tang, Tracy T.
    Moy, Ryan H.
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancers
    Luo, Mengxin
    Xu, Yongjin
    Chen, Haifeng
    Wu, Yiquan
    Pang, Ao
    Hu, Junjie
    Dong, Xiaowu
    Che, Jinxin
    Yang, Haiyan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 244
  • [3] Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review
    Crawford, James J.
    Bronner, Sarah M.
    Zbieg, Jason R.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28 (12) : 867 - 873
  • [4] YAP/TAZ-TEAD link angiogenesis to nutrients
    Oberkersch, Roxana E.
    Santoro, Massimo M.
    NATURE METABOLISM, 2022, 4 (06) : 645 - 646
  • [5] Targeting YAP/TAZ-TEAD signaling as a therapeutic approach in head and neck squamous cell carcinoma
    Sato, Kuniaki
    Faraji, Farhoud
    Cervantes-Villagrana, Rodolfo Daniel
    Wu, Xingyu
    Koshizuka, Keiichi
    Ishikawa, Tomohiko
    Iglesias-Bartolome, Ramiro
    Chen, Lei
    de Marval, Paula L. Miliani
    Gwaltney, Stephen L.
    Adler, Benjamin
    Gutkind, J. Silvio
    CANCER LETTERS, 2025, 612
  • [6] The novel potent Pan-TEAD inhibitor, SB6863, inhibits oncogenic YAP1/TAZ-TEAD signaling and exhibits robust tumor regression in preclinical mesothelioma models
    Lee, O. Y.
    Jeong, Y.
    Park, Y.
    Kim, J. G.
    Choi, S.
    Jung, H. S.
    Kong, Y.
    Baek, G. R.
    Kim, J. H.
    Kim, H. E.
    Yoo, J. W.
    Park, J. H.
    Jeong, H. U.
    Park, H.
    Kim, M. K.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S52 - S52
  • [7] A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
    Pobbati, Ajaybabu, V
    Hong, Wanjin
    THERANOSTICS, 2020, 10 (08): : 3622 - 3635
  • [8] Covalent pan-TEAD inhibitors for the treatment of cancers with Hippo pathway alterations
    Guo, S.
    Huang, C.
    Shrishrimal, S.
    Cui, J.
    Zhang, V.
    Deng, N.
    Dong, I.
    Wang, G.
    Begley, C. G.
    Luo, S.
    Cao, P.
    Wiedemeyer, W.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S41 - S41
  • [9] Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complex
    Che, Kepeng
    Pobbati, Ajaybabu, V
    Seavey, Caleb N.
    Fedorov, Yuriy
    Komar, Anton A.
    Burtscher, Ashley
    Ma, Shuang
    Rubin, Brian P.
    PLOS ONE, 2022, 17 (04):
  • [10] Inhibition of YAP/TAZ-TEAD activity induces cytotrophoblast differentiation into syncytiotrophoblast in human trophoblast
    Mizutani, Tetsuya
    Orisaka, Makoto
    Miyazaki, Yumiko
    Morichika, Ririko
    Uesaka, Miki
    Miyamoto, Kaoru
    Yoshida, Yoshio
    MOLECULAR HUMAN REPRODUCTION, 2022, 28 (10)
12345